Meanwhile, in a new development for type two diabetes patients in the US, the Food and Drug Administration (FDA) has approved a new drug for use.
Known as tirzepatide, the drug is injected into diabetics once a week.
As well as lowering blood sugar, the drug also supports weight loss.
Weight, alongside poor diet, is a key risk factor for type two diabetes.
